Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

AXL targeting overcomes human lung cancer cell resistance to NK and CTL-mediated cytotoxicity.

Terry S, Abdou A, Engelsen AST, Buart S, Dessen P, Corgnac S, Collares D, Meurice G, Gausdal G, Baud V, Saintigny P, Lorens JB, Thiery JP, Mami-Chouaib F, Chouaib S.

Cancer Immunol Res. 2019 Sep 5. pii: canimm.0903.2019. doi: 10.1158/2326-6066.CIR-18-0903. [Epub ahead of print]

PMID:
31488404
2.

Molecular analysis of vascular smooth muscle cells from patients with giant cell arteritis: Targeting endothelin-1 receptor to control proliferation.

Régent A, Ly KH, Groh M, Khifer C, Lofek S, Clary G, Chafey P, Baud V, Broussard C, Federici C, Labrousse F, Mesturoux L, Le Jeunne C, Vidal E, Brezin A, Witko-Sarsat V, Guillevin L, Mouthon L.

Autoimmun Rev. 2017 Apr;16(4):398-406. doi: 10.1016/j.autrev.2017.02.006. Epub 2017 Feb 14. Review.

PMID:
28232168
3.

Cutting Edge: NANOG Activates Autophagy under Hypoxic Stress by Binding to BNIP3L Promoter.

Hasmim M, Janji B, Khaled M, Noman MZ, Louache F, Bordereaux D, Abderamane A, Baud V, Mami-Chouaib F, Chouaib S.

J Immunol. 2017 Feb 15;198(4):1423-1428. doi: 10.4049/jimmunol.1600981. Epub 2017 Jan 16.

4.

Model of the Interaction between the NF-κB Inhibitory Protein p100 and the E3 Ubiquitin Ligase β-TrCP based on NMR and Docking Experiments.

Melikian M, Eluard B, Bertho G, Baud V, Evrard-Todeschi N.

J Chem Inf Model. 2017 Feb 27;57(2):223-233. doi: 10.1021/acs.jcim.5b00409. Epub 2017 Jan 13.

PMID:
28004927
5.

Post-Translational Modifications of RelB NF-κB Subunit and Associated Functions.

Baud V, Collares D.

Cells. 2016 May 4;5(2). pii: E22. doi: 10.3390/cells5020022. Review.

6.

Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status.

Messai Y, Gad S, Noman MZ, Le Teuff G, Couve S, Janji B, Kammerer SF, Rioux-Leclerc N, Hasmim M, Ferlicot S, Baud V, Mejean A, Mole DR, Richard S, Eggermont AM, Albiges L, Mami-Chouaib F, Escudier B, Chouaib S.

Eur Urol. 2016 Oct;70(4):623-632. doi: 10.1016/j.eururo.2015.11.029. Epub 2015 Dec 23.

PMID:
26707870
7.

Astrocyte Transcriptome from the Mecp2(308)-Truncated Mouse Model of Rett Syndrome.

Delépine C, Nectoux J, Letourneur F, Baud V, Chelly J, Billuart P, Bienvenu T.

Neuromolecular Med. 2015 Dec;17(4):353-63. doi: 10.1007/s12017-015-8363-9. Epub 2015 Jul 25.

PMID:
26208914
8.

Rapid childhood T-ALL growth in xenograft models correlates with mature phenotype and NF-κB pathway activation but not with poor prognosis.

Poglio S, Cahu X, Uzan B, Besnard-Guérin C, Lapillonne H, Leblanc T, Baruchel A, Landman-Parker J, Petit A, Baleydier F, Amsellem S, Baud V, Ballerini P, Pflumio F.

Leukemia. 2015 Apr;29(4):977-80. doi: 10.1038/leu.2014.317. Epub 2014 Nov 5. No abstract available.

PMID:
25371179
9.

ITPR1 protects renal cancer cells against natural killer cells by inducing autophagy.

Messai Y, Noman MZ, Hasmim M, Janji B, Tittarelli A, Boutet M, Baud V, Viry E, Billot K, Nanbakhsh A, Ben Safta T, Richon C, Ferlicot S, Donnadieu E, Couve S, Gardie B, Orlanducci F, Albiges L, Thiery J, Olive D, Escudier B, Chouaib S.

Cancer Res. 2014 Dec 1;74(23):6820-32. doi: 10.1158/0008-5472.CAN-14-0303. Epub 2014 Oct 8.

10.

IKK phosphorylates RelB to modulate its promoter specificity and promote fibroblast migration downstream of TNF receptors.

Authier H, Billot K, Derudder E, Bordereaux D, Rivière P, Rodrigues-Ferreira S, Nahmias C, Baud V.

Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14794-9. doi: 10.1073/pnas.1410124111. Epub 2014 Sep 29.

11.

Interleukin-18 produced by bone marrow-derived stromal cells supports T-cell acute leukaemia progression.

Uzan B, Poglio S, Gerby B, Wu CL, Gross J, Armstrong F, Calvo J, Cahu X, Deswarte C, Dumont F, Passaro D, Besnard-Guérin C, Leblanc T, Baruchel A, Landman-Parker J, Ballerini P, Baud V, Ghysdael J, Baleydier F, Porteu F, Pflumio F.

EMBO Mol Med. 2014 Jun;6(6):821-34. doi: 10.1002/emmm.201303286. Epub 2014 Apr 6.

12.

GH administration rescues fatty liver regeneration impairment by restoring GH/EGFR pathway deficiency.

Collin de l'Hortet A, Zerrad-Saadi A, Prip-Buus C, Fauveau V, Helmy N, Ziol M, Vons C, Billot K, Baud V, Gilgenkrantz H, Guidotti JE.

Endocrinology. 2014 Jul;155(7):2545-54. doi: 10.1210/en.2014-1010. Epub 2014 Apr 7.

PMID:
24708244
13.

Cutting edge: Hypoxia-induced Nanog favors the intratumoral infiltration of regulatory T cells and macrophages via direct regulation of TGF-β1.

Hasmim M, Noman MZ, Messai Y, Bordereaux D, Gros G, Baud V, Chouaib S.

J Immunol. 2013 Dec 15;191(12):5802-6. doi: 10.4049/jimmunol.1302140. Epub 2013 Nov 13.

14.

Thrombopoietin promotes NHEJ DNA repair in hematopoietic stem cells through specific activation of Erk and NF-κB pathways and their target, IEX-1.

de Laval B, Pawlikowska P, Barbieri D, Besnard-Guerin C, Cico A, Kumar R, Gaudry M, Baud V, Porteu F.

Blood. 2014 Jan 23;123(4):509-19. doi: 10.1182/blood-2013-07-515874. Epub 2013 Nov 1.

15.

A Mendelian predisposition to B-cell lymphoma caused by IL-10R deficiency.

Neven B, Mamessier E, Bruneau J, Kaltenbach S, Kotlarz D, Suarez F, Masliah-Planchon J, Billot K, Canioni D, Frange P, Radford-Weiss I, Asnafi V, Murugan D, Bole C, Nitschke P, Goulet O, Casanova JL, Blanche S, Picard C, Hermine O, Rieux-Laucat F, Brousse N, Davi F, Baud V, Klein C, Nadel B, Ruemmele F, Fischer A.

Blood. 2013 Nov 28;122(23):3713-22. doi: 10.1182/blood-2013-06-508267. Epub 2013 Oct 2.

16.

Frequent engagement of RelB activation is critical for cell survival in multiple myeloma.

Cormier F, Monjanel H, Fabre C, Billot K, Sapharikas E, Chereau F, Bordereaux D, Molina TJ, Avet-Loiseau H, Baud V.

PLoS One. 2013;8(3):e59127. doi: 10.1371/journal.pone.0059127. Epub 2013 Mar 28.

17.

RelB inhibits cell proliferation and tumor growth through p53 transcriptional activation.

Jacque E, Billot K, Authier H, Bordereaux D, Baud V.

Oncogene. 2013 May 23;32(21):2661-9. doi: 10.1038/onc.2012.282. Epub 2012 Jul 9.

PMID:
22777360
18.

Attenuation of soft-tissue sarcomas resistance to the cytotoxic action of TNF-α by restoring p53 function.

Muret J, Hasmim M, Stasik I, Jalil A, Mallavialle A, Nanbakhsh A, Lacroix L, Billot K, Baud V, Thiery J, Vielh P, Terrier P, Wiels J, Vassilev L, Lecesne A, Bonvalot S, Chouaib S.

PLoS One. 2012;7(6):e38808. doi: 10.1371/journal.pone.0038808. Epub 2012 Jun 18.

19.

[Refusal to eat. A stress situation for nurses].

Baud V, Forestier J.

Krankenpfl Soins Infirm. 2012;105(4):54-7. French. No abstract available.

PMID:
22545518
20.

Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice.

Anson M, Crain-Denoyelle AM, Baud V, Chereau F, Gougelet A, Terris B, Yamagoe S, Colnot S, Viguier M, Perret C, Couty JP.

J Clin Invest. 2012 Feb;122(2):586-99. doi: 10.1172/JCI43937. Epub 2012 Jan 17.

21.

A Novel Cellular Model to Study Angiotensin II AT2 Receptor Function in Breast Cancer Cells.

Rodrigues-Ferreira S, Morel M, Reis RI, Cormier F, Baud V, Costa-Neto CM, Nahmias C.

Int J Pept. 2012;2012:745027. doi: 10.1155/2012/745027. Epub 2011 Dec 6.

22.

Autophagy is required for the activation of NFκB.

Criollo A, Chereau F, Malik SA, Niso-Santano M, Mariño G, Galluzzi L, Maiuri MC, Baud V, Kroemer G.

Cell Cycle. 2012 Jan 1;11(1):194-9. doi: 10.4161/cc.11.1.18669. Epub 2012 Jan 1. Erratum in: Cell Cycle. 2012 Dec 15;11(24):4673.

PMID:
22186785
23.

Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia.

Tailler M, Senovilla L, Lainey E, Thépot S, Métivier D, Sébert M, Baud V, Billot K, Fenaux P, Galluzzi L, Boehrer S, Kroemer G, Kepp O.

Oncogene. 2012 Jul 26;31(30):3536-46. doi: 10.1038/onc.2011.521. Epub 2011 Nov 21.

PMID:
22105358
24.

A20-binding inhibitor of nuclear factor-kappaB (NF-kappaB)-2 (ABIN-2) is an activator of inhibitor of NF-kappaB (IkappaB) kinase alpha (IKKalpha)-mediated NF-kappaB transcriptional activity.

Leotoing L, Chereau F, Baron S, Hube F, Valencia HJ, Bordereaux D, Demmers JA, Strouboulis J, Baud V.

J Biol Chem. 2011 Sep 16;286(37):32277-88. doi: 10.1074/jbc.M111.236448. Epub 2011 Jul 22.

25.

Similar NF-κB gene signatures in TNF-α treated human endothelial cells and breast tumor biopsies.

Perrot-Applanat M, Vacher S, Toullec A, Pelaez I, Velasco G, Cormier F, Saad Hel S, Lidereau R, Baud V, Bièche I.

PLoS One. 2011;6(7):e21589. doi: 10.1371/journal.pone.0021589. Epub 2011 Jul 6.

26.

Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors.

Delahaye NF, Rusakiewicz S, Martins I, Ménard C, Roux S, Lyonnet L, Paul P, Sarabi M, Chaput N, Semeraro M, Minard-Colin V, Poirier-Colame V, Chaba K, Flament C, Baud V, Authier H, Kerdine-Römer S, Pallardy M, Cremer I, Peaudecerf L, Rocha B, Valteau-Couanet D, Gutierrez JC, Nunès JA, Commo F, Bonvalot S, Ibrahim N, Terrier P, Opolon P, Bottino C, Moretta A, Tavernier J, Rihet P, Coindre JM, Blay JY, Isambert N, Emile JF, Vivier E, Lecesne A, Kroemer G, Zitvogel L.

Nat Med. 2011 Jun;17(6):700-7. doi: 10.1038/nm.2366. Epub 2011 May 8.

PMID:
21552268
27.

GH receptor plays a major role in liver regeneration through the control of EGFR and ERK1/2 activation.

Zerrad-Saadi A, Lambert-Blot M, Mitchell C, Bretes H, Collin de l'Hortet A, Baud V, Chereau F, Sotiropoulos A, Kopchick JJ, Liao L, Xu J, Gilgenkrantz H, Guidotti JE.

Endocrinology. 2011 Jul;152(7):2731-41. doi: 10.1210/en.2010-1193. Epub 2011 May 3.

PMID:
21540290
28.

Control of NF-κB activity by proteolysis.

Baud V, Derudder E.

Curr Top Microbiol Immunol. 2011;349:97-114. doi: 10.1007/82_2010_101. Review.

PMID:
21267708
29.

Deregulation of Aiolos expression in chronic lymphocytic leukemia is associated with epigenetic modifications.

Billot K, Soeur J, Chereau F, Arrouss I, Merle-Béral H, Huang ME, Mazier D, Baud V, Rebollo A.

Blood. 2011 Feb 10;117(6):1917-27. doi: 10.1182/blood-2010-09-307140. Epub 2010 Dec 7.

30.

Dichotomy between factors inducing the immunosuppressive enzyme IL-4-induced gene 1 (IL4I1) in B lymphocytes and mononuclear phagocytes.

Marquet J, Lasoudris F, Cousin C, Puiffe ML, Martin-Garcia N, Baud V, Chereau F, Farcet JP, Molinier-Frenkel V, Castellano F.

Eur J Immunol. 2010 Sep;40(9):2557-68. doi: 10.1002/eji.201040428.

31.

IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia.

Chapuis N, Park S, Leotoing L, Tamburini J, Verdier F, Bardet V, Green AS, Willems L, Agou F, Ifrah N, Dreyfus F, Bismuth G, Baud V, Lacombe C, Mayeux P, Bouscary D.

Blood. 2010 Nov 18;116(20):4240-50. doi: 10.1182/blood-2009-12-260711. Epub 2010 Jul 29.

32.

IKK connects autophagy to major stress pathways.

Criollo A, Senovilla L, Authier H, Maiuri MC, Morselli E, Vitale I, Kepp O, Tasdemir E, Galluzzi L, Shen S, Tailler M, Delahaye N, Tesniere A, De Stefano D, Younes AB, Harper F, Pierron G, Lavandero S, Zitvogel L, Israel A, Baud V, Kroemer G.

Autophagy. 2010 Jan;6(1):189-91. Review.

PMID:
20110771
33.

The IKK complex contributes to the induction of autophagy.

Criollo A, Senovilla L, Authier H, Maiuri MC, Morselli E, Vitale I, Kepp O, Tasdemir E, Galluzzi L, Shen S, Tailler M, Delahaye N, Tesniere A, De Stefano D, Younes AB, Harper F, Pierron G, Lavandero S, Zitvogel L, Israel A, Baud V, Kroemer G.

EMBO J. 2010 Feb 3;29(3):619-31. doi: 10.1038/emboj.2009.364. Epub 2009 Dec 3.

34.

Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls.

Baud V, Karin M.

Nat Rev Drug Discov. 2009 Jan;8(1):33-40. doi: 10.1038/nrd2781. Review.

35.

[The alternative NF-kB activation pathway and cancer: friend or foe?].

Baud V, Jacque E.

Med Sci (Paris). 2008 Dec;24(12):1083-8. doi: 10.1051/medsci/200824121083. Review. French.

36.

[RelA, a new player in the regulation of RelB activity].

Jacque E, Baud V.

Med Sci (Paris). 2006 Feb;22(2):113-4. French. No abstract available.

37.

RelA repression of RelB activity induces selective gene activation downstream of TNF receptors.

Jacque E, Tchenio T, Piton G, Romeo PH, Baud V.

Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14635-40. Epub 2005 Sep 28.

38.

Identification and characterization of p100HB, a new mutant form of p100/NF-kappa B2.

Derudder E, Laferté A, Ferreira V, Mishal Z, Baud V, Tarantino N, Körner M.

Biochem Biophys Res Commun. 2003 Sep 5;308(4):744-9.

PMID:
12927781
39.

RelB/p50 dimers are differentially regulated by tumor necrosis factor-alpha and lymphotoxin-beta receptor activation: critical roles for p100.

Derudder E, Dejardin E, Pritchard LL, Green DR, Korner M, Baud V.

J Biol Chem. 2003 Jun 27;278(26):23278-84. Epub 2003 Apr 21.

40.

Oxidative stress and gene expression: the AP-1 and NF-kappaB connections.

Karin M, Takahashi T, Kapahi P, Delhase M, Chen Y, Makris C, Rothwarf D, Baud V, Natoli G, Guido F, Li N.

Biofactors. 2001;15(2-4):87-9. Review. No abstract available.

PMID:
12016332
41.

Signal transduction by tumor necrosis factor and its relatives.

Baud V, Karin M.

Trends Cell Biol. 2001 Sep;11(9):372-7. Review.

PMID:
11514191
42.

IKKbeta is essential for protecting T cells from TNFalpha-induced apoptosis.

Senftleben U, Li ZW, Baud V, Karin M.

Immunity. 2001 Mar;14(3):217-30.

43.

IKKalpha controls formation of the epidermis independently of NF-kappaB.

Hu Y, Baud V, Oga T, Kim KI, Yoshida K, Karin M.

Nature. 2001 Apr 5;410(6829):710-4.

PMID:
11287960
45.

Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase.

Hu Y, Baud V, Delhase M, Zhang P, Deerinck T, Ellisman M, Johnson R, Karin M.

Science. 1999 Apr 9;284(5412):316-20.

46.

PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia.

Abo A, Qu J, Cammarano MS, Dan C, Fritsch A, Baud V, Belisle B, Minden A.

EMBO J. 1998 Nov 16;17(22):6527-40.

47.

EMR1, an unusual member in the family of hormone receptors with seven transmembrane segments.

Baud V, Chissoe SL, Viegas-Péquignot E, Diriong S, N'Guyen VC, Roe BA, Lipinski M.

Genomics. 1995 Mar 20;26(2):334-44.

PMID:
7601460
48.

The E subunit of vacuolar H(+)-ATPase localizes close to the centromere on human chromosome 22.

Baud V, Mears AJ, Lamour V, Scamps C, Duncan AM, McDermid HE, Lipinski M.

Hum Mol Genet. 1994 Feb;3(2):335-9.

PMID:
8004105
49.

The human homolog of the mouse common viral integration region, FLI1, maps to 11q23-q24.

Baud V, Lipinski M, Rassart E, Poliquin L, Bergeron D.

Genomics. 1991 Sep;11(1):223-4.

PMID:
1765382
50.

[Facilitating contact between mother and child. A survey carried out in a neonatology service].

Baud V, Christol M.

Soins Gynecol Obstet Pueric Pediatr. 1989 Mar;(94):40-4. French. No abstract available.

PMID:
2727872

Supplemental Content

Support Center